StockDrifts LogoStockDrifts

Infinite Healthcare 071200

Company
인피니트헬스케어Infinite Healthcare
Insiders
1
Buys
4
Total Value
₩2.2B ($1.5M)
Avg Return
+25.25%
Last Filing
2026-03-25

Infinite Healthcare (071200) has 4 disclosed insider purchases and 0 disclosed disposals on record, filed by 1 distinct insiders. Together those filings cover ₩2.2B ($1.5M) in reported transaction value. The earliest filing StockDrifts holds for Infinite Healthcare is dated 2024-10-14; the most recent is 2026-03-25. Across these filings the average return since disclosure is +25.25%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

Recent insider trades

DateTypeSourceInsiderPositionSharesPrice at filingReturnValue
2026-03-25BUYMarket Buy
솔본
Solbon
-24.4K₩6,390-3.8%₩156M ($108K)
2026-01-12BUY신규선임
김대은
Dae-eun Kim
moving10₩5,950+13.1%₩60K ($41)
2025-08-18BUYMarket Buy
솔본
Solbon
-51.6K₩6,620+1.7%₩342M ($237K)
2024-10-22BUYMarket Buy
솔본
Solbon
-44.2K₩4,518+49.0%₩200M ($139K)
2024-10-14BUYMarket Buy
솔본
Solbon
-333.3K₩4,366+54.1%₩1.5B ($1.0M)

Frequently asked questions

Who has been buying Infinite Healthcare stock?
1 distinct insiders have filed 4 disclosed insider purchases in Infinite Healthcare (071200), most recently on 2026-03-25. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Infinite Healthcare have?
Infinite Healthcare has 4 buy-side and 0 sell-side disclosures on record, covering ₩2.2B ($1.5M) in total reported value, spanning 2024-10-14 to 2026-03-25.
Do insider buys in Korean stocks predict returns?
Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean regulatory filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

More on this data

Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.